Radio and PodcastRadio and PodcastLive Radio & Podcasts
EP 144: ESC 25 in Review with Dr Purvi Parwani artwork
Science & Medicine

EP 144: ESC 25 in Review with Dr Purvi Parwani

Parallax by Ankur Kalra by Parallax by Ankur Kalra

Oct 13, 202501:05:25Science & Medicine

In this evidence-packed episode of Parallax, Dr Ankur Kalra welcomes back Dr Purvi Parwani, Associate Professor of Medicine at Loma Linda University Health, for a comprehensive review of groundbreaking trials presented a...

About This Episode

EP 144: ESC 25 in Review with Dr Purvi Parwani is an episode from Parallax by Ankur Kalra by Parallax by Ankur Kalra. In this evidence-packed episode of Parallax, Dr Ankur Kalra welcomes back Dr Purvi Parwani, Associate Professor of Medicin...

Podcast

This episode belongs to Parallax by Ankur Kalra.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Oct 13, 2025, 01:05:25 long, audio available.

Questions About This Episode

What is EP 144: ESC 25 in Review with Dr Purvi Parwani about?

In this evidence-packed episode of Parallax, Dr Ankur Kalra welcomes back Dr Purvi Parwani, Associate Professor of Medicine at Loma Linda University Health, for a comprehensive review of groundbreaking trials presented at the European Society of Cardiology Congress. Dr Parwani guides listeners through what she describes as a "tectonic shift" in post-MI care with the REBOOT and BETAMI-DANBLOCK trials. These studies challenge the routine use of beta blockers after heart attack, revealing that patients with preserved ejection fraction above 50% may not benefit, while those with EF between 40-49% show significant risk reduction from continued therapy. The discussion moves to heart failure management, exploring the POTCAST trial's approach to optimising potassium levels in high-risk patients and the DIGIT-HF trial's examination of digitoxin as a potential option for patients who cannot tolerate modern four-pillar therapy. Dr Kalra and Dr Parwani conclude with the evolving role of aspirin in cardiovascular care. They discuss findings from NEO-MINDSET, TARGET-FIRST, and the AQUATIC trial, which together are reshaping antiplatelet strategies from the immediate post-PCI period through long-term management of stable coronary disease in patients requiring anticoagulation. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

Where can I listen to EP 144: ESC 25 in Review with Dr Purvi Parwani?

You can listen to EP 144: ESC 25 in Review with Dr Purvi Parwani online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is EP 144: ESC 25 in Review with Dr Purvi Parwani from?

EP 144: ESC 25 in Review with Dr Purvi Parwani is an episode from Parallax by Ankur Kalra by Parallax by Ankur Kalra.

How long is this episode?

This episode is 01:05:25 long.

When was this episode published?

This episode was published on Oct 13, 2025.

Can I save EP 144: ESC 25 in Review with Dr Purvi Parwani for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from Parallax by Ankur Kalra?

Yes. This page shows related episodes from Parallax by Ankur Kalra when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to EP 144: ESC 25 in Review with Dr Purvi Parwani?

You can listen to EP 144: ESC 25 in Review with Dr Purvi Parwani on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

EP 144: ESC 25 in Review with Dr Purvi Parwani is from Parallax by Ankur Kalra by Parallax by Ankur Kalra.

What are the episode details?

Published Oct 13, 2025 and 01:05:25 long